Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis
- PMID: 10864618
- PMCID: PMC1736996
- DOI: 10.1136/jnnp.69.1.121
Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis
Abstract
Sialorrhoea is a socially disabling problem in bulbar amyotrophic lateral sclerosis (ALS). Botulinum toxin A (BoNT/A) was injected into the salivary glands in five patients with bulbar ALS and sialorrhoea. The effect of BoNT/A was measured by the number of paper handkerchiefs used each day and by salivary gland scintigraphy. BoNT/A ameliorated sialorrhoea and quality of life without major adverse effects. BoNT/A may be a relatively safe and effective treatment for sialorrhoea in selected patients.
Comment in
-
Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach.J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):417-8. doi: 10.1136/jnnp.70.3.417. J Neurol Neurosurg Psychiatry. 2001. PMID: 11248905 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous